Two Sigma Advisers’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-11,800
| Closed | -$19.7K | – | 1167 |
|
|
2025
Q4 | $19.7K | Buy |
11,800
+100
| +0.9% | +$173 | ﹤0.01% | 2315 |
|
|
2025
Q3 | $19.8K | Sell |
11,700
-2,800
| -19% | -$3.31K | ﹤0.01% | 2300 |
|
|
2025
Q2 | $13.2K | Sell |
14,500
-208,864
| -94% | -$124K | ﹤0.01% | 2293 |
|
|
2025
Q1 | $101K | Buy |
223,364
+136,400
| +157% | +$80K | ﹤0.01% | 2241 |
|
|
2024
Q4 | $43.7K | Buy |
86,964
+65,864
| +312% | +$48.4K | ﹤0.01% | 2292 |
|
|
2024
Q3 | $19.1K | Sell |
21,100
-1,400
| -6% | -$1.3K | ﹤0.01% | 2253 |
|
|
2024
Q2 | $22.4K | Sell |
22,500
-9,900
| -31% | -$10.9K | ﹤0.01% | 2398 |
|
|
2024
Q1 | $48K | Sell |
32,400
-5,500
| -15% | -$6.24K | ﹤0.01% | 2351 |
|
|
2023
Q4 | $41.3K | Sell |
37,900
-1,200
| -3% | -$1.31K | ﹤0.01% | 2412 |
|
|
2023
Q3 | $46.1K | Sell |
39,100
-10,499
| -21% | -$14.3K | ﹤0.01% | 2282 |
|
|
2023
Q2 | $69.9K | Sell |
49,599
-17,500
| -26% | -$24.2K | ﹤0.01% | 2243 |
|
|
2023
Q1 | $101K | Sell |
67,099
-22,064
| -25% | -$30.8K | ﹤0.01% | 2385 |
|
|
2022
Q4 | $104K | Sell |
89,163
-130,900
| -59% | -$165K | ﹤0.01% | 2291 |
|
|
2022
Q3 | $249K | Sell |
220,063
-43,003
| -16% | -$63.1K | ﹤0.01% | 2134 |
|
|
2022
Q2 | $416K | Sell |
263,066
-352,700
| -57% | -$465K | ﹤0.01% | 2001 |
|
|
2022
Q1 | $948K | Sell |
615,766
-474,600
| -44% | -$736K | ﹤0.01% | 1665 |
|
|
2021
Q4 | $2.67M | Sell |
1,090,366
-22,000
| -2% | -$51.5K | 0.01% | 1049 |
|
|
2021
Q3 | $2.8M | Sell |
1,112,366
-712,200
| -39% | -$1.83M | 0.01% | 1069 |
|
|
2021
Q2 | $5.2M | Buy |
1,824,566
+190,700
| +12% | +$493K | 0.01% | 851 |
|
|
2021
Q1 | $3.84M | Buy |
1,633,866
+1,124,000
| +220% | +$2.7M | 0.01% | 967 |
|
|
2020
Q4 | $897K | Buy |
509,866
+172,200
| +51% | +$241K | ﹤0.01% | 1608 |
|
|
2020
Q3 | $316K | Buy |
337,666
+45,900
| +16% | +$40.5K | ﹤0.01% | 1991 |
|
|
2020
Q2 | $254K | Buy |
291,766
+58,200
| +25% | +$51.2K | ﹤0.01% | 2183 |
|
|
2020
Q1 | $193K | Sell |
233,566
-12,800
| -5% | -$12.7K | ﹤0.01% | 2179 |
|
|
2019
Q4 | $219K | Buy |
246,366
+58,400
| +31% | +$48.6K | ﹤0.01% | 2156 |
|
|
2019
Q3 | $184K | Buy |
187,966
+17,977
| +11% | +$18.6K | ﹤0.01% | 2057 |
|
|
2019
Q2 | $187K | Buy |
169,989
+28,300
| +20% | +$32.6K | ﹤0.01% | 2144 |
|
|
2019
Q1 | $186K | Sell |
141,689
-12,564
| -8% | -$15.6K | ﹤0.01% | 2129 |
|
|
2018
Q4 | $141K | Buy |
154,253
+57,838
| +60% | +$88.6K | ﹤0.01% | 2188 |
|
|
2018
Q3 | $198K | Sell |
96,415
-10,745
| -10% | -$22.6K | ﹤0.01% | 2086 |
|
|
2018
Q2 | $193K | Buy |
107,160
+36,005
| +51% | +$72.5K | ﹤0.01% | 2205 |
|
|
2018
Q1 | $167K | Sell |
71,155
-31,776
| -31% | -$74.5K | ﹤0.01% | 2168 |
|
|
2017
Q4 | $194K | Buy |
102,931
+83,214
| +422% | +$182K | ﹤0.01% | 2093 |
|
|
2017
Q3 | $49K | Buy |
19,717
+4,458
| +29% | +$11.1K | ﹤0.01% | 2152 |
|
|
2017
Q2 | $42K | Buy |
+15,259
| New | +$42.6K | ﹤0.01% | 2216 |
|
|
2017
Q1 | – | Sell |
-11,659
| Closed | -$37K | – | 2409 |
|
|
2016
Q4 | $37K | Sell |
11,659
-2,171
| -16% | -$6.67K | ﹤0.01% | 2305 |
|
|
2016
Q3 | $47K | Buy |
+13,830
| New | +$38.2K | ﹤0.01% | 2177 |
|
Other funds holding LCTX
BC
VCM
DC
RA
AC
